Steven Callaghan

1.9k total citations
15 papers, 1.6k citations indexed

About

Steven Callaghan is a scholar working on Molecular Biology, Oncology and Cell Biology. According to data from OpenAlex, Steven Callaghan has authored 15 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 8 papers in Oncology and 4 papers in Cell Biology. Recurrent topics in Steven Callaghan's work include Cell death mechanisms and regulation (6 papers), Cancer-related Molecular Pathways (6 papers) and Palliative Care and End-of-Life Issues (3 papers). Steven Callaghan is often cited by papers focused on Cell death mechanisms and regulation (6 papers), Cancer-related Molecular Pathways (6 papers) and Palliative Care and End-of-Life Issues (3 papers). Steven Callaghan collaborates with scholars based in Canada, United States and Saudi Arabia. Steven Callaghan's co-authors include David S. Park, Ruth S. Slack, Sean P. Cregan, Jason G. MacLaurin, Andre Fortin, Michael J. O’Hare, Patrick Swan, Valina L. Dawson, Ted M. Dawson and Seong-Woon Yu and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Journal of Neuroscience.

In The Last Decade

Steven Callaghan

14 papers receiving 1.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Steven Callaghan Canada 12 1.0k 384 370 299 210 15 1.6k
Subhas C. Biswas India 23 1.1k 1.1× 246 0.6× 205 0.6× 343 1.1× 185 0.9× 59 1.8k
Girish Putcha United States 15 1.5k 1.4× 298 0.8× 230 0.6× 386 1.3× 198 0.9× 27 2.1k
Attila Lehotzky Hungary 21 944 0.9× 218 0.6× 294 0.8× 172 0.6× 235 1.1× 36 1.6k
Guanghong Liao United States 19 887 0.8× 146 0.4× 322 0.9× 320 1.1× 393 1.9× 29 1.7k
Nicholas T. Hertz United States 20 1.3k 1.2× 147 0.4× 465 1.3× 303 1.0× 230 1.1× 24 1.8k
Lynn Bedford United Kingdom 18 1.1k 1.1× 237 0.6× 361 1.0× 165 0.6× 343 1.6× 21 1.6k
Jaya Padmanabhan United States 26 1.3k 1.2× 479 1.2× 353 1.0× 327 1.1× 88 0.4× 52 2.2k
Franca Codazzi Italy 25 1.1k 1.0× 133 0.3× 348 0.9× 432 1.4× 141 0.7× 54 2.1k
Roman Urfer United States 22 1.1k 1.1× 188 0.5× 201 0.5× 726 2.4× 88 0.4× 28 1.8k
Harald Frankowski United States 16 1.5k 1.4× 116 0.3× 470 1.3× 711 2.4× 372 1.8× 18 2.4k

Countries citing papers authored by Steven Callaghan

Since Specialization
Citations

This map shows the geographic impact of Steven Callaghan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Steven Callaghan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Steven Callaghan more than expected).

Fields of papers citing papers by Steven Callaghan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Steven Callaghan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Steven Callaghan. The network helps show where Steven Callaghan may publish in the future.

Co-authorship network of co-authors of Steven Callaghan

This figure shows the co-authorship network connecting the top 25 collaborators of Steven Callaghan. A scholar is included among the top collaborators of Steven Callaghan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Steven Callaghan. Steven Callaghan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Callaghan, Steven, et al.. (2025). Intensity of Care at the End-of-Life in Pediatrics: A Single Center Analysis With Implications for Advanced Care Planning in Saudi Arabia. American Journal of Hospice and Palliative Medicine®. 746594655–746594655.
4.
Swan, Patrick, et al.. (2010). Neuronal Apoptosis Induced by Endoplasmic Reticulum Stress Is Regulated by ATF4–CHOP-Mediated Induction of the Bcl-2 Homology 3-Only Member PUMA. Journal of Neuroscience. 30(50). 16938–16948. 284 indexed citations
5.
Zhang, Yi, Dianbo Qu, Erick J. Morris, et al.. (2006). The Chk1/Cdc25A Pathway as Activators of the Cell Cycle in Neuronal Death Induced by Camptothecin. Journal of Neuroscience. 26(34). 8819–8828. 46 indexed citations
6.
Crocker, Stephen J., Shawn Hayley, Patrice D. Smith, et al.. (2005). Regulation of axotomy‐induced dopaminergic neuron death and c‐Jun phosphorylation by targeted inhibition of cdc42 or mixed lineage kinase. Journal of Neurochemistry. 96(2). 489–499. 13 indexed citations
7.
O’Hare, Michael J., Neena Kushwaha, Ying Zhang, et al.. (2005). Differential Roles of Nuclear and Cytoplasmic Cyclin-Dependent Kinase 5 in Apoptotic and Excitotoxic Neuronal Death. Journal of Neuroscience. 25(39). 8954–8966. 111 indexed citations
8.
Rashidian, Juliet, Grace O. Iyirhiaro, Hossein Aleyasin, et al.. (2005). Multiple cyclin-dependent kinases signals are critical mediators of ischemia/hypoxic neuronal death in vitro and in vivo. Proceedings of the National Academy of Sciences. 102(39). 14080–14085. 114 indexed citations
9.
Ni, Zuyao, Elizabeth Karaskov, Tao Yu, et al.. (2005). Apical role for BRG1 in cytokine-induced promoter assembly. Proceedings of the National Academy of Sciences. 102(41). 14611–14616. 78 indexed citations
10.
Cregan, Sean P., Nicole Arbour, Jason G. MacLaurin, et al.. (2004). p53 Activation Domain 1 Is Essential for PUMA Upregulation and p53-Mediated Neuronal Cell Death. Journal of Neuroscience. 24(44). 10003–10012. 83 indexed citations
11.
Fortin, Andre, Jason G. MacLaurin, Nicole Arbour, et al.. (2004). The Proapoptotic Gene SIVA Is a Direct Transcriptional Target for the Tumor Suppressors p53 and E2F1. Journal of Biological Chemistry. 279(27). 28706–28714. 69 indexed citations
12.
Smith, Patrice D., Stephen J. Crocker, Vernice Jackson‐Lewis, et al.. (2003). Cyclin-dependent kinase 5 is a mediator of dopaminergic neuron loss in a mouse model of Parkinson's disease. Proceedings of the National Academy of Sciences. 100(23). 13650–13655. 256 indexed citations
13.
Cregan, Sean P., Andre Fortin, Jason G. MacLaurin, et al.. (2002). Apoptosis-inducing factor is involved in the regulation of caspase-independent neuronal cell death. The Journal of Cell Biology. 158(3). 507–517. 412 indexed citations
14.
Ferguson, Kerry L., Steven Callaghan, Michael J. O’Hare, David S. Park, & Ruth S. Slack. (2000). The Rb-CDK4/6 Signaling Pathway Is Critical in Neural Precursor Cell Cycle Regulation. Journal of Biological Chemistry. 275(43). 33593–33600. 67 indexed citations
15.
Callaghan, Debbie, et al.. (1999). Neural Precursor Cells Differentiating in the Absence of Rb Exhibit Delayed Terminal Mitosis and Deregulated E2F 1 and 3 Activity. Developmental Biology. 207(2). 257–270. 67 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026